http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104667263-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate | 2014-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104667263-B |
| titleOfInvention | The atomized inhalation of interferon-' alpha ' and budesonide |
| abstract | The invention belongs to the compositions field of antiviral drugs, it is related to the atomized inhalation of interferon-' alpha ' and budesonide.Described atomized inhalation contains the interferon-' alpha ' of therapeutically effective amount, budesonide, and the pharmaceutically acceptable auxiliaries of Sq；It is preferred that the interferon-' alpha ' containing 10 50 μ g in unit dosage form, 0.25 1.5mg budesonide, and the pharmaceutically acceptable auxiliaries of Sq；Interferon-' alpha ' containing 20 30 μ g more preferably in unit dosage form, 0.5 1mg budesonide, and the pharmaceutically acceptable auxiliaries of Sq.Viral pneumonia is treated with the interferon-' alpha ' of the present invention and the atomized inhalation of budesonide, interferon-' alpha ' can relatively be used alone or budesonide treatment significantly improves curative effect. |
| priorityDate | 2014-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.